(19)
(11) EP 3 096 817 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
26.12.2018 Bulletin 2018/52

(45) Mention of the grant of the patent:
24.10.2018 Bulletin 2018/43

(21) Application number: 15740635.6

(22) Date of filing: 20.01.2015
(51) International Patent Classification (IPC): 
A61M 5/158(2006.01)
A61M 37/00(2006.01)
A61B 17/34(2006.01)
A61M 5/168(2006.01)
A61M 25/06(2006.01)
(86) International application number:
PCT/US2015/012005
(87) International publication number:
WO 2015/112486 (30.07.2015 Gazette 2015/30)

(54)

PERCUTANEOUS DELIVERY DEVICE FOR TENDON-LIGAMENT-MUSCLE REPAIR

PERKUTANE FREISETZUNGSVORRICHTUNG FÜR SEHNEN-BÄNDER-MUSKEL-REPARATUR

DISPOSITIF D'ADMINISTRATION PERCUTANÉE DE RÉPARATION DE TENDON-LIGAMENT-MUSCLE


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 22.01.2014 US 201461930155 P

(43) Date of publication of application:
30.11.2016 Bulletin 2016/48

(73) Proprietor: Regenexx, LLC
Des Moines, Iowa 50321 (US)

(72) Inventors:
  • CENTENO, Christopher
    Broomfield, Colorado 80021 (US)
  • REISCHLING, Patrick
    Broomfield, Colorado 80021 (US)
  • SNYDER, Timothy
    Broomfield, Colorado 80021 (US)

(74) Representative: Naylor, Matthew John et al
Mewburn Ellis LLP
City Tower 40 Basinghall Street London EC2V 5DE
City Tower 40 Basinghall Street London EC2V 5DE (GB)


(56) References cited: : 
US-A- 5 762 636
US-A1- 2004 138 562
US-A1- 2005 125 002
US-A1- 2006 217 655
US-A- 5 860 953
US-A1- 2004 147 877
US-A1- 2006 167 416
US-A1- 2011 276 001
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).